RPA1 and cancer: In line with the role of proper RPA acetylation in DSB repair, cells expressing the 3KQ mutant allele had a severe defect in resistance to Iniparib, an anti-cancer agent, and the 3KR mutant lines also exhibited a reduced resistance to the drug, albeit to a lesser extent (Figure 7F).